Related Experiment Video

Updated: Jul 4, 2026

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
07:22

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells

Published on: March 28, 2013

Anticancer Properties of PPARalpha-Effects on Cellular Metabolism and Inflammation

Maja Grabacka1, Krzysztof Reiss

  • 1Department of Food Biotechnology, Faculty of Food Technology, Agricultural University of Krakow, ul. Balicka 122, 31149 Krakow, Poland.

PPAR Research
|May 30, 2008
PubMed

Insights

Peroxisome proliferator-activated receptors (PPARs), particularly PPARalpha ligands, show promise as low-toxicity anticancer agents. They target cancer cell metabolism, inhibit proliferation, and suppress inflammation, offering new therapeutic avenues for disseminated cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Metabolic Research

Background:

  • Peroxisome proliferator-activated receptors (PPARs) are established therapeutic targets for metabolic diseases.
  • PPAR ligands modulate glucose and lipid metabolism gene expression.
  • Emerging research highlights PPAR ligands as potential anticancer agents with low systemic toxicity.

Purpose of the Study:

  • To discuss the potential roles of PPARalpha ligands in tumor suppression.
  • To explore the anticancer mechanisms of PPARalpha activation.
  • To evaluate PPARalpha ligands as novel therapeutic agents for disseminated cancer.

Main Methods:

  • Review of existing literature on PPARalpha and cancer.
  • Analysis of PPARalpha's effects on cancer cell energy metabolism (fatty acid synthesis and oxidation).
  • Investigation of PPARalpha's interaction with AMP-dependent protein kinase and its impact on oncogenic pathways.

Main Results:

  • PPARalpha activation targets cancer cell energy balance by inhibiting fatty acid synthesis and promoting beta-oxidation.
  • PPARalpha cooperates with AMP-dependent protein kinase to repress oncogenic Akt activity and inhibit proliferation in nutrient-limited environments.
  • PPARalpha demonstrates anti-inflammatory effects and upregulates uncoupling proteins (UCPs), reducing reactive oxygen species production and cell proliferation.

Conclusions:

  • PPARalpha ligands exhibit antiproliferative, proapoptotic, anti-inflammatory, and antimetastatic properties.
  • PPARalpha activation can induce 'metabolic catastrophe' in glycolysis-dependent cancer cells.
  • Low-toxicity PPAR ligands represent promising therapeutic candidates for combating disseminated cancer.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...